Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.

T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells. Cytotherapy. 2015 Sep; 17(9):1280-91.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.